Search research articles
Contact Us
Filters
Showing results (71-80 of 108) with videos related to
Page
of 11
Sort By:
Internal Medicine (Tokyo, Japan)
|
October 1, 2020
Successful Treatment with Afatinib after Osimertinib-induced Interstitial Lung Disease in a Patient with EGFR-mutant Non-small-cell Lung Cancer
Shunichi Nishima, Akihiko Miyanaga, Sho Saito, et al.
Oncotargets and Therapy
|
June 14, 2022
Successful Treatment with Short-Term Steroid Against Severe Hepatitis Confirmed by Liver Biopsy in a Patient with Advanced Squamous-Cell Lung Cancer Receiving a Combination of Pembrolizumab, Carboplatin, and Nab-Paclitaxel: A Case Report
Anna Hayashi, Shinji Nakamichi, Yukako Nakayama, et al.
Communications Biology
|
April 22, 2024
Disulfiram treatment suppresses antibody-producing reactions by inhibiting macrophage activation and B cell pyrimidine metabolism
Weili Chen, Etsuko Toda, Kazuhiro Takeuchi, et al.
Oncotargets and Therapy
|
June 29, 2023
Remarkable Clinical Response of <i>ALK</i>-Rearranged/<i>TP53</i>-Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report
Hirokazu Iso, Akihiko Miyanaga, Naohiro Kadoma, et al.
Translational Lung Cancer Research
|
April 15, 2026
Prognostic impact of thyroid transcription factor-1 expression and the efficacy of carboplatin plus (nab-) paclitaxel in non-squamous non-small cell lung cancer complicated with idiopathic interstitial pneumonias
Yuto Terashima, Aya Fukuizumi, Koichiro Kamio, et al.
Scientific Reports
|
February 15, 2017
TAZ contributes to pulmonary fibrosis by activating profibrotic functions of lung fibroblasts
Satoshi Noguchi, Akira Saito, Yu Mikami, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
February 3, 2019
Molecular hydrogen attenuates gefitinib-induced exacerbation of naphthalene-evoked acute lung injury through a reduction in oxidative stress and inflammation
Yasuhiro Terasaki, Tetsuya Suzuki, Kozue Tonaki, et al.
Kidney International Reports
|
July 31, 2024
Myeloperoxidase-Associated Membranous Nephropathy in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis
Kenta Tominaga, Etsuko Toda, Kazuhiro Takeuchi, et al.
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi
|
January 17, 2024
Clinicopathological Characteristics of Everolimus-Associated Interstitial Lung Disease: A Single-Center Consecutive Analysis
Yoshinobu Saito, Yasuhiro Terasaki, Takeru Kashiwada, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
July 19, 2011
Hydrogen therapy attenuates irradiation-induced lung damage by reducing oxidative stress
Yasuhiro Terasaki, Ikuroh Ohsawa, Mika Terasaki, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 108) with videos related to
Sort By:
Page
of 11
Internal Medicine (Tokyo, Japan)
|
October 1, 2020
Successful Treatment with Afatinib after Osimertinib-induced Interstitial Lung Disease in a Patient with EGFR-mutant Non-small-cell Lung Cancer
Shunichi Nishima, Akihiko Miyanaga, Sho Saito, et al.
Oncotargets and Therapy
|
June 14, 2022
Successful Treatment with Short-Term Steroid Against Severe Hepatitis Confirmed by Liver Biopsy in a Patient with Advanced Squamous-Cell Lung Cancer Receiving a Combination of Pembrolizumab, Carboplatin, and Nab-Paclitaxel: A Case Report
Anna Hayashi, Shinji Nakamichi, Yukako Nakayama, et al.
Communications Biology
|
April 22, 2024
Disulfiram treatment suppresses antibody-producing reactions by inhibiting macrophage activation and B cell pyrimidine metabolism
Weili Chen, Etsuko Toda, Kazuhiro Takeuchi, et al.
Oncotargets and Therapy
|
June 29, 2023
Remarkable Clinical Response of <i>ALK</i>-Rearranged/<i>TP53</i>-Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report
Hirokazu Iso, Akihiko Miyanaga, Naohiro Kadoma, et al.
Translational Lung Cancer Research
|
April 15, 2026
Prognostic impact of thyroid transcription factor-1 expression and the efficacy of carboplatin plus (nab-) paclitaxel in non-squamous non-small cell lung cancer complicated with idiopathic interstitial pneumonias
Yuto Terashima, Aya Fukuizumi, Koichiro Kamio, et al.
Scientific Reports
|
February 15, 2017
TAZ contributes to pulmonary fibrosis by activating profibrotic functions of lung fibroblasts
Satoshi Noguchi, Akira Saito, Yu Mikami, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
February 3, 2019
Molecular hydrogen attenuates gefitinib-induced exacerbation of naphthalene-evoked acute lung injury through a reduction in oxidative stress and inflammation
Yasuhiro Terasaki, Tetsuya Suzuki, Kozue Tonaki, et al.
Kidney International Reports
|
July 31, 2024
Myeloperoxidase-Associated Membranous Nephropathy in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis
Kenta Tominaga, Etsuko Toda, Kazuhiro Takeuchi, et al.
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi
|
January 17, 2024
Clinicopathological Characteristics of Everolimus-Associated Interstitial Lung Disease: A Single-Center Consecutive Analysis
Yoshinobu Saito, Yasuhiro Terasaki, Takeru Kashiwada, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
July 19, 2011
Hydrogen therapy attenuates irradiation-induced lung damage by reducing oxidative stress
Yasuhiro Terasaki, Ikuroh Ohsawa, Mika Terasaki, et al.
Page
of 11